When: Flush to $260-265 on heavy volume followed by reversal day with macro stabilization

Then: Upgrade to Overweight

When: Confirmed daily close >$290 on >6M volume with 3-day follow-through AND evidence of yield regime softening

Then: Upgrade to Overweight with measured add

When: Q3 prints revenue ≥$5.5B + FCF ≥$1.8B + GM ≥60% with FY2026 FCF guide to $7B+

Then: Upgrade to Overweight on confirmation

HOLD - do not add until pullback to 265-270 zone or confirmed macro pivot; keep current position, maintain stop at 258, deploy incremental capital to cash or short-duration Treasuries

• RSI at 62.97 pressing upper Bollinger band at 282.22 near swing high of 284.39 in a 1.314 beta name signals short-term exhaustion rather than bullish continuation
• Q2 2026 FCF of 2.19 billion is an anomaly (Q1: 840M, Q4 2025: 1.33B, Q3 2025: 990M); TTM FCF of 3.55 billion does not support annualized dividend of 5.2 billion
• Forward P/E of 26.5x is fair price for 35 percent ROE quality asset, not a compelling entry
• 30-year Treasury at 2002 highs is structural term premium shift, not priced-in transient; Polymarket shows 96 percent odds of no 2026 cuts
• Stop at 245.55 (200 SMA) risks 14 percent drawdown; proposed stop at 258 respects September structure and caps downside at 8.5 percent
• Add at 278 versus 265 is 5 percent cost basis difference, which can become 10 percent against position in single week given beta and rates environment
• Prefer waiting for tested supports at 50 SMA, VWMA, or Bollinger middle band where actual buyers have accumulated
• Collect 2.18 percent dividend while waiting; short-duration Treasuries yielding 5 percent provide alternatives to deploying capital at upper-band prices

→ vs aggressive: Annualizing Q2 FCF of 2.19 billion and projecting forward is optimistic extrapolation; TTM of 3.55 billion reflects weaker prior quarters and dividend coverage concern is structural, not a trough distortion

→ vs aggressive: MACD crossover being two weeks old with histogram already showing signs of reversal; horizontal Bollinger bandwidth expansion at upper band with elevated beta is buying exhaustion, not momentum

→ vs aggressive: 'Priced in' framing on 30-year at 2002 highs ignores that multiple compression in rising-rates regime is a process, not a one-time event; hot CPI could drive yields higher and compress multiples further while earnings revise lower

→ vs aggressive: Low retail attention does not equal coiled setup; institutional silence on TXN signals analysts are waiting for next data point, not confirmed bullish thesis

→ vs aggressive: Stop at 245.55 (200 SMA) is reckless—10 percent adverse move on beta-amplified name in hostile macro is realistic scenario, not normal volatility shakeout

→ vs aggressive: Adding at 278 then setting aggressive stop below creates blended basis meaningfully higher; concentration risk disguised as conviction

HOLD current position; do not add aggressively at current levels; define add triggers at 265-272 zone with confirmation signals; maintain 258 stop; wait 2-4 weeks for Q3 2026 catalyst clarity

• 22.8% revenue acceleration is lapping the trough quarter of an industrial cycle (base effect)
• Q3 2025 FCF was 990 million; Q1 2026 FCF was 840 million; Q2 2026 FCF was 2.19 billion; honest base case for forward FCF is 6-7 billion range
• TTM FCF of 3.55 billion against 5.2 billion in dividends, but TXN has 7 billion in cash and short-term investments with 4.86 current ratio
• Dividend coverage gap is transitional (capex rolling off) not permanent
• 30-year at 2002 highs is a regime change in term premium, not a one-time shock
• 1.3 beta means cost of being early is real; yields are a risk to manage through position sizing
• 258 stop respects September structure and swing low at 258.44; 245 stop (200 SMA) is thesis-invalidation level not a stop level
• Stock has rallied from 253 low to 281 in eight sessions and sits above 50 SMA, 10 EMA, VWMA; not being ignored
• Q3 2026 print is the right catalyst but should be treated as scenario input for position sizing, not binary trigger
• 2.18% dividend yield plus FCF inflection optionality is reasonable carry while waiting
• Add trigger framework: wait for 265-272 zone with one of three confirmations (daily close below 10 EMA with RSI toward 50, volume spike exceeding average, or constructive macro data)
• Macro invalidation rule: if 30-year breaks above recent highs and CPI prints hot, pause add thesis even if price reaches zone
• If breakout above 284 occurs, ratchet stop to 270 or higher

→ vs aggressive: 258 stop is appropriate; 245.55 stop at 200 SMA is reckless (14% adverse move before acknowledging thesis failure); 'coiled setup' is dangerous oversell given institutional waiting behavior and FCF base effects; 'priced in' argument fails because multiple compression is a process not an event

→ vs conservative: Dividend coverage concern is technically accurate but practically overstated (gap is capex, not operations; coverage improves mechanically as capex rolls off); 'wait for macro pivot' is too restrictive (macro doesn't resolve on schedule; may miss move at 290+); 'no narrative means correctly ignored' is wrong (stock is being accumulated quietly by institutional buyers above multiple moving averages)